Overview
The Machaca Lab is interested in the regulation of Ca²+ signaling pathways under both physiological and pathological conditions. Ca²+ signals are ubiquitous and are involved in a plethora of cell physiological processes including fertilization, cell proliferation, and gene expression. Our interest in the basic cellular and molecular mechanisms of Ca²+ signaling is framed in the context of several projects that the Lab is presently focused on.
We have a long standing interest in the regulation and remodeling of Ca²+ signaling pathways during the meiotic cell cycle. Before becoming fertilization competent oocytes undergo a maturation period - oocyte maturation - which encompasses entry into meiosis and dramatic remodeling of Ca²+ signaling pathways. This is a physiologically attractive model because a Ca²+ signal at fertilization is the universal trigger to induce egg activation in all sexually reproducing species tested to date. We are interested in the mechanisms mediating this molecular remodeling of Ca²+ signals during meiotic maturation. Such remodeling includes the IP3-dependent Ca²+ release, the plasma membrane Ca²+-ATPase at the cell membrane, and store- operated Ca²+ entry (see Figure). Ongoing projects in the Lab are focused on understanding the regulation of IP3-dependent Ca²+ release and store-operated Ca²+ entry (SOCE) during the meiotic cell cycle. This includes the basic molecular regulation of the two key molecules in SOCE, STIM1 and Orai1. STIM1 is the ER Ca²+ sensor that detects Ca²+ store depletion and activates the plasma membrane channel Orai1. We are further interested in the regulation of the IP3 receptor during hypertension in vascular smooth cells in a collaborative project with the Rusch Lab.
We are also interested in the regulation of the cell division phase by transition metals. We have discovered that transition metal chelation arrests the meiotic cell cycle through interfering with the function of the dual specificity phosphatase Cdc25C, a central player in the regulation of meiotic progression.
Highlights
- 1iScience · 2024
- 2The Journal of cell biology · 2024
- 3PLoS biology · 2020
Publications
Funding
Active
5 grants- KPModulation of obesity and thermogenesis by intracellular calcium signallingQatar National Research Fund · 2025–2028ARG02-0421-240243
- PIClinical personalized medicine to treat immunodeficiencies: Combining multiomics with functional characterization using cellular models to inform clinical treatmentQatar National Research Fund · 2024–2027PPM 06-0508-230025
- Sub-PIImproving Diagnostic Yield in Genome-Negative Families with Multi-omics – Towards Personalized Medicine for Rare DisordersQatar National Research Fund · 2024–2027 · via Sidra Medical and Research CenterPPM 06-0507-230014
- PIRegulation of inter-organelle membrane contact sitesQatar National Research Fund · 2024–2027ARG01-0517-230201
- KPUnraveling the molecular mechanisms underlying the ability of PLC-zeta to trigger mammalian oocyte activation and early embryonic developmentQatar National Research Fund · 2023–2026 · via Qatar UniversityNPRP-BSRA01-0504-210082
Completed grants (6)
- Co-ITargeting membrane progesterone receptors to improve insulin resistanceQatar National Research Fund · 2021–2024NPRP13S-0206-200274
- PIPhysiological association between diabetes mellitus and cardiac arrhythmiaQatar National Research Fund · 2020–2024NPRP12S-0212-190074
- Sub-PIUnlocking precision medicine potential through functional genomic studies in the diagnosis of inherited immunodeficiency diseasesQatar National Research Fund · 2021–2023 · via Sidra Medical and Research CenterPPM 04-0128-200015
- PIAddgene 492139Addgene, Inc. · 2019–2020ContractAddgene 492139
- PIInterplay Between Ca2+ Release and Ca2+ Entry Pathways in Hypertension-Induced Vascular RemodelingQatar National Research Fund · 2016–2019NPRP 8-110-3-021
- PIRegulation of Calcium Signaling during OogenesisNIGMS · 2000–2011 · via NIH RePORTERR01GM061829-10
News mentions
- Qatar Project Highlights the Importance of Population-Specific Genetic Screening Tools for Personalized MedicineJanuary 19, 2022
A team led by collaborating researchers from Weill Cornell Medicine, Weill Cornell Medicine—Qatar and Qatar Foundation have assembled a large genomic database on the Qatari people, and have used it to develop an advanced but low-cost screening tool for genetic diseases in this highly distinct Middle Eastern population.
Mentoring
External relationships
Advisory/Scientific Board Member
Aqur Biosciences INC · L'Oreal USA · ScieNFT
Other
Third Bridge